Physician profile
Marc Gruner
NPI 1760877492
$1,156.86
in general payments reported to CMS, 2019-2025
13 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $228 · 2021: $245 · 2022: $289 · 2023: $111 · 2024: $52.60 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $247.72 | 2020-2025 | Xcell |
| Smith+Nephew, INC. | $178.11 | 2022 | |
| Allergan, INC. | $175.15 | 2020-2022 | |
| Sonex Health, INC. | $128.90 | 2020 | |
| Medtronic, INC. | $110.85 | 2023 | Intellis Adaptivestim |
| Tenex Health INC. | $78.17 | 2021 | |
| Abbvie INC. | $76.78 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $35.03 | 2020 | |
| Depuy Synthes Sales INC. | $33.64 | 2024 | Peak, Monovisc, Orthovisc |
| Collegium Pharmaceutical, INC. | $31.73 | 2022 | |
| Almatica Pharma LLC | $31.42 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.61 | 2021 | |
| Lilly USA, LLC | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Gruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.